Avery Dennison (AVY) SVP Colisto reports 2026 stock awards and vesting

Rhea-AI Filing Summary

Avery Dennison SVP & CIO Nicholas Colisto reported equity compensation activity involving restricted stock units, performance units, and common stock on 2026-03-01. He received a 2026 RSU Award for 1,462 units and a 2026 PU Award for 2,114 units, each representing the right to one share of common stock if vesting conditions are met.

Multiple tranches of prior-year market stock unit and performance unit awards vested into common shares, with related common stock transactions at $194.78 per share. Some of these shares were delivered back to the company to satisfy tax withholding obligations, leaving Colisto with 11,012 shares of common stock held directly after the reported transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Colisto Nicholas

(Last) (First) (Middle)

8080 NORTON PARKWAY

(Street)

MENTOR OH 44060

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Avery Dennison Corp [ AVY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & CIO

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		M		370	A	$194.78	9,758	D
Common Stock	03/01/2026		F		110	D	$194.78	9,648	D
Common Stock	03/01/2026		M		348	A	$194.78	9,996	D
Common Stock	03/01/2026		F		90	D	$194.78	9,906	D
Common Stock	03/01/2026		M		251	A	$194.78	10,157	D
Common Stock	03/01/2026		F		62	D	$194.78	10,095	D
Common Stock	03/01/2026		M		431	A	$194.78	10,526	D
Common Stock	03/01/2026		F		105	D	$194.78	10,421	D
Common Stock	03/01/2026		M		782	A	$194.78	11,203	D
Common Stock	03/01/2026		F		191	D	$194.78	11,012	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2026 RSU Award	$0	03/01/2026		A		1,462		03/01/2027(1)	03/01/2030	Common Stock	1,462	$0	1,462	D
2026 PU Award	$0	03/01/2026		A		2,114		03/01/2029(2)	03/01/2029	Common Stock	2,114	$0	2,114	D
2022 MSU Award	$0	03/01/2026		M			370	03/01/2023(3)	03/01/2026	Common Stock	370	$0	0	D
2023 MSU Award	$0	03/01/2026		M			348	03/01/2024(4)	03/01/2027	Common Stock	348	$0	344	D
2024 MSU Award	$0	03/01/2026		M			251	03/01/2025(5)	03/01/2028	Common Stock	251	$0	528	D
2025 MSU Award	$0	03/01/2026		M			431	03/01/2026(6)	03/01/2029	Common Stock	431	$0	1,348	D
2023 PU Award	$0	03/01/2026		M			782	03/01/2026(7)	03/01/2026	Common Stock	782	$0	0	D

Explanation of Responses:

1. Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock.

2. Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock.

3. Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period.

4. Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period.

5. Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period.

6. Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period.

7. Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target.

	/s/ Vikas Arora attorney-in-fact for Nicholas Colisto	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.